Close
ACHEMA MIDDLE EAST 2026

E&L Testing Market Growth To Be Driven By Single-Use Systems

The worldwide extractable and leachable- E&L testing services market is all set to value $2.57 million by 2030, as per the latest report by...

Largest Reorganization In History of FDA On Table In 2024

It is well to be noted that a proposed FDA reorganization might as well have food safety first and foremost; however, stakeholders throughout industries...

CAR-NK Cell Therapy Trial Long-Term Findings Get Revealed

In a recent development, researchers from the US have gone on to report some promising outcomes out of a Phase I/II trial when it...

Cancer Care Whole Genome Sequencing: Compelling Proof Found

Blending the routine clinical data along with the whole genome sequence- WSG data at scale goes on to support clinicians when it comes to...

2024 Has A Lot Many Questions In Store For Pharma Companies

The advent of powerful new drugs in the case of obesity has gone on to reshape the pharma sector, thereby transforming Eli Lilly as...

UK Study Supports Whole Genome Sequencing In Cancer Care

A novel benchmark study in the UK has gone on to show that blending whole-genome sequencing- WGS and real-world clinical data at a national...

AI Can Indeed Revolutionize The Pharma Compound Synthesis

Researchers from the University of Cambridge, UK, along with a leading global pharmaceutical company, have gone on to develop an AI-powered platform that can...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...